Cargando…

Anthracyclines in the treatment of patients with early breast cancer

Detalles Bibliográficos
Autores principales: Guarneri, V., de Azambuja, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271479/
https://www.ncbi.nlm.nih.gov/pubmed/35798471
http://dx.doi.org/10.1016/j.esmoop.2022.100461
_version_ 1784744689347330048
author Guarneri, V.
de Azambuja, E.
author_facet Guarneri, V.
de Azambuja, E.
author_sort Guarneri, V.
collection PubMed
description
format Online
Article
Text
id pubmed-9271479
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-92714792022-07-12 Anthracyclines in the treatment of patients with early breast cancer Guarneri, V. de Azambuja, E. ESMO Open Pro and Con Discussion Elsevier 2022-04-19 /pmc/articles/PMC9271479/ /pubmed/35798471 http://dx.doi.org/10.1016/j.esmoop.2022.100461 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Pro and Con Discussion
Guarneri, V.
de Azambuja, E.
Anthracyclines in the treatment of patients with early breast cancer
title Anthracyclines in the treatment of patients with early breast cancer
title_full Anthracyclines in the treatment of patients with early breast cancer
title_fullStr Anthracyclines in the treatment of patients with early breast cancer
title_full_unstemmed Anthracyclines in the treatment of patients with early breast cancer
title_short Anthracyclines in the treatment of patients with early breast cancer
title_sort anthracyclines in the treatment of patients with early breast cancer
topic Pro and Con Discussion
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271479/
https://www.ncbi.nlm.nih.gov/pubmed/35798471
http://dx.doi.org/10.1016/j.esmoop.2022.100461
work_keys_str_mv AT guarneriv anthracyclinesinthetreatmentofpatientswithearlybreastcancer
AT deazambujae anthracyclinesinthetreatmentofpatientswithearlybreastcancer